Mahana™ IBS is a prescription digital therapeutic designed to help people diagnosed with irritable bowel syndrome (IBS). The 3-month digital therapy program is FDA-cleared and clinically validated to reduce the severity of IBS symptoms. The program delivers IBS targeted cognitive behavioral therapy to help build a healthier brain-gut relationship, decrease symptom severity, and increase overall well-being. During the program, users will track symptoms and triggers, manage flare-ups, change unhelpful behaviors and thoughts, and build personalized techniques for lasting IBS relief. Mahana IBS is intended to be used together with other IBS treatments and has no known side effects.

The Mahana program features 10 sessions focused on key areas such as understanding symptoms and stress, managing IBS symptoms, improving eating routines with food, improving exercise habits, recognizing unhelpful thoughts, finding alternative thoughts, learning relaxation techniques, managing sleep and stress, managing emotions, and building strategies for long-term relief. As users progress, they will complete short interactive lessons and unlock new tools to support their journey. For the best results, the program should be used daily.

Testimonials from users have shown significant improvement in overall symptoms and relief from IBS attacks. Mahana IBS is not intended to be a substitute for medications or as a replacement for care by a healthcare provider, and it is not intended to communicate any emergency, urgent, or critical information to providers.

To start the program, users can visit www.mahanatx.com/treatments/ibs to be connected to a provider and obtain a prescription through a simple and easy telehealth consultation or their healthcare provider.

Overall, Mahana IBS is a clinically proven and effective digital therapeutic designed to help people with IBS manage their symptoms and improve their overall well-being.